- Home
- IMVT vs GNW Comparison
IMVT vs GNW Comparison
Compare IMVT & GNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- GNW
- Stock Information
- Founded
- IMVT 2018
- GNW 1871
- Country
- IMVT United States
- GNW United States
- Employees
- IMVT N/A
- GNW N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- GNW Life Insurance
- Sector
- IMVT Health Care
- GNW Finance
- Exchange
- IMVT Nasdaq
- GNW Nasdaq
- Market Cap
- IMVT 2.8B
- GNW 2.9B
- IPO Year
- IMVT N/A
- GNW 2004
- Fundamental
- Price
- IMVT $16.95
- GNW $7.99
- Analyst Decision
- IMVT Buy
- GNW Buy
- Analyst Count
- IMVT 10
- GNW 1
- Target Price
- IMVT $40.14
- GNW $9.00
- AVG Volume (30 Days)
- IMVT 1.4M
- GNW 8.0M
- Earning Date
- IMVT 08-05-2025
- GNW 07-30-2025
- Dividend Yield
- IMVT N/A
- GNW N/A
- EPS Growth
- IMVT N/A
- GNW 141.92
- EPS
- IMVT N/A
- GNW 0.49
- Revenue
- IMVT N/A
- GNW $7,217,000,000.00
- Revenue This Year
- IMVT N/A
- GNW N/A
- Revenue Next Year
- IMVT N/A
- GNW N/A
- P/E Ratio
- IMVT N/A
- GNW $15.21
- Revenue Growth
- IMVT N/A
- GNW N/A
- 52 Week Low
- IMVT $12.72
- GNW $5.95
- 52 Week High
- IMVT $34.47
- GNW $8.01
- Technical
- Relative Strength Index (RSI)
- IMVT 60.86
- GNW 66.07
- Support Level
- IMVT $15.80
- GNW $7.73
- Resistance Level
- IMVT $17.06
- GNW $7.97
- Average True Range (ATR)
- IMVT 0.68
- GNW 0.24
- MACD
- IMVT 0.07
- GNW 0.04
- Stochastic Oscillator
- IMVT 86.70
- GNW 98.41
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.